[go: up one dir, main page]

Eto et al., 1986 - Google Patents

Further studies on the inhibition of pepsin by bile salts

Eto et al., 1986

View PDF
Document ID
8540851279672422119
Author
Eto T
Tompkins R
Publication year
Publication venue
Annals of surgery

External Links

Snippet

A higher incidence of peptic ulceration has been reported in patients recovering from operations that divert bile from the duodenum. Previous studies have shown that hydroxylated bile salts inhibit the proteolytic activity of pepsin, an integral agent in the …
Continue reading at pmc.ncbi.nlm.nih.gov (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients

Similar Documents

Publication Publication Date Title
Grossman Gastrointestinal hormones
Playford et al. Human spasmolytic polypeptide is a cytoprotective agent that stimulates cell migration
Velázquez et al. Butyrate and the colonocyte: production, absorption, metabolism, and therapeutic implications
Layer et al. Altered postprandial motility in chronic pancreatitis: role of malabsorption
JP3403496B2 (en) Anti-ulcer agent and Helicobacter pylori colonization inhibitor
Suzuki et al. Anti-ulcer effects of 4'-(2-carboxyetyl) phenyl trans-4-aminomethyl cyclohexanecarboxylate hydrochloride (cetraxate) on various experimental gastric ulcers in rats
DE3480903D1 (en) PHARMACEUTICAL COMPOSITIONS WITH INSULIN CONTENT.
BR9713921A (en) Compound, pharmaceutical composition, process for logician capable of being modulated through factor xa inhibition
Eto et al. Further studies on the inhibition of pepsin by bile salts
Mössner et al. Influence of treatment with pancreatic extracts on pancreatic enzyme secretion.
Mössner Is there a place for pancreatic enzymes in the treatment of pain in chronic pancreatitis?
Silk et al. Hydrolysis of peptides within lumen of small intestine
Laperche et al. Effects of phenobarbital and rose bengal on the ATPases of plasma membranes of rat and rabbit liver
Firth et al. Keratinocyte growth factor 1 inhibits wound edge epithelial cell apoptosis in vitro
ATE198049T1 (en) TREATMENT OF STOMACH AND INTESTINAL ULCERS WITH MORPHOGENS
Brown et al. Drug treatment for acute upper gastrointestinal bleeding
Toyoda et al. Physiological factors controlling release of enterokinase from rat enterocytes
Shea-Donohue et al. Alterations in gastric mucus secretion in rhesus monkeys after exposure to ionizing radiation
Hull et al. Healing with basic fibroblast growth factor is associated with reduced indomethacin induced relapse in a human model of gastric ulceration.
Mossner et al. Influence of exogenous application of pancreatic extracts on endogenous pancreatic enzyme secretion
CN115364193A (en) Application of millet protein hydrolysate in preparation of functional food or medicine for preventing or treating gastric ulcer
Olds et al. Differential immunoregulation of granulomatous inflammation, portal hypertension, and hepatic fibrosis in murine schistosomiasis mansoni.
Eto et al. Inhibition of pepsin activity by ursodeoxycholic acids and chenodeoxycholic acids
Hahn et al. Morphology of gastrointestinal effects of aspirin
Komarov The Inactivation of Pepsin and Its Relation to Peptic Ulcer∗.